1.. INTRODUCTION {#sec1}
================

Thalassemia is a blood related genetic condition which characterized by decreased synthesis of one of the two types of polypeptide chains (α or β) ([@ref1]). This disorder encompasses the lack of or errors in genes accountable for the construction of hemoglobin, a protein present in the red blood cells ([@ref2]). The World Health Organization (WHO) announced that the frequency of thalassemia and abnormal hemoglobin carriers is 5.1% with nearly 226 million carriers worldwide ([@ref2], [@ref3]). Nearly 80% of thalassemia cases worldwide are detected in the area extending from sub-Saharan Africa to the Mediterranean Basin, the Middle East, and South and Southeast Asia ([@ref4]).

Currently, as a result of important clinical and scientific improvements, thalassemia and other hemoglobin disorders are considered as remediable and preventable in cases where effective national programmers are in place and where there is free access to quality healthcare for people living with these conditions ([@ref5]). The management of thalassemia patients is compound and requires a multidisciplinary strategy that integrates clinically and the laboratory features ([@ref6]). As with other chronic disease management, the healthcare procedure is long-lasting and continuous of consisting multiple different parts of the process ([@ref7]). Therefore, having IT tools such as healthcare systems to assist the progression can improve the healthcare services quality ([@ref8]). Besides providing more accurate and timely information regarding patient care, it has been found to improve the efficiency of healthcare organization services especially in terms of patient data management ([@ref9]).

Several approaches are being applied across different healthcare systems around the world, including the use of patient registries, which have been identified as a method of improving quality and cost efficiency in health and healthcare ([@ref10], [@ref11]). High quality patient registries provide valuable contributions to designate demographics, clinical features and to determine baseline prevalence and variation in practices 'in the real world' ([@ref12]-[@ref14]). They let surveillance of important health conditions, a better understanding of patient health status and requirements, evaluate changing practice and trends over time, and allow predictions for resource requirements ([@ref15], [@ref16]).

A thalassemia registry encompasses comprehensive information related to thalassemia patients, over many years ([@ref17], [@ref18]). Moreover, the thalassemia registry provides data on access to and quality of care, and patient outcomes such as survival and Quality of life ([@ref19], [@ref20]). It has successfully followed changing dynamics and healthcare requirements and allowed detection of health system faults to aids, not only disease research but also the development and evaluation of a prevention program and the creation of clinical strategies ([@ref18], [@ref21]). In recent years, the thalassemia registry has been considered as an important tool for monitoring and improving the quality of patient care ([@ref1], [@ref22]). European Medicines Agency (EMA) recognizes the need for common approaches to foster the optimal use of national and multinational registries ([@ref23]).

2.. AIM {#sec2}
=======

The objective of this study was to identify existing thalassemia registries in worldwide and describe their main characteristics including objectives, data sources, responsible institutions, core data set and the process of registration in different countries.

3.. METHODS {#sec3}
===========

We reviewed the literature reporting on thalassemia registries. The databases PubMed, Scopus, ProQuest, and Science Direct were searched up until September 2018. In addition, Google and Google Scholar were searched for thalassemia registry websites, unpublished studies and grey literature. There was no restriction on date of publication. The keywords used for the search were the following; Thalassemia, Hemoglobinopathy, Surveillance, Registry and Database. All documents and reports on thalassemia registries were included if they provided details about the program characteristics. We did not apply language constraints and provided a translation service if needed for non-English documents. The references of found articles were used to identify other related articles. In addition, we contacted the authors of the included studies to ask if they were aware of any further registries.

In this study we did not set any language restrictions, we used only English search words. After a complete search, all search results were reviewed separately based on studies title or running title and relevant documents were selected. The duplicated documents were excluded. Afterward agreement on the final included studies was reached, one author independently extracted data using a standard data extraction form, which was then cross-checked by the second reviewer. If the contact details were provided in retrieved sources, an email was sent to a registry manager asking for additional peer-reviewed publications and other resources, such as conference presentations and annual reports. In case of no response, two follow-up reminders were sent. The unknown field for incomplete/not response was entered into the data extraction table.

![Preferred reporting items for reviews flow diagram](AIM-27-58-g001){#fig1}

Based on retrieved peer-reviewed publications and gray literature, the selected thalassemia registries were further analyzed to obtain the following information: (a) region, (b) country, (c) registry name, (d) responsible institutes, (e) Internet home page, (f) type of registry, (g) institution year, (h) funding sources, (i) objectives, (j) diseases coverage, (k) language of collected data, (l) participation type, (m) core data set, (n) data sources, and (o) methods of data collection.

4.. RESULTS {#sec4}
===========

Using the search strategies, 149 references were identified and 12 papers (13, 14, 16-20, 22, 24-27) met the inclusion criteria ([Figure 1](#fig1){ref-type="fig"}). We identified 16 thalassemia registries (set up from 1984 and 2016). Out of total amount, 13 registries were national, 1 multinational and 2 regional. The identified registries were established in 14 countries distributed in Asia (n=4), Europe (n=9), North America (n=2), and Oceania (n=1). No thalassemia registry was identified in Africa and South America ([Table 1](#table1){ref-type="table"}). Six registries were specifically designed to collect data on thalassemia patients and 10 were hemoglobinopathies registries including also thalassemia patients.

Moreover, Government funding was the most common funding source for registries. Only the National Hemoglobinopathies Registry in Greece was private funded. The time length of funding was not reported. The objectives of most thalassemia registries were improving diagnosis and management of control programs. Other purposes of thalassemia registries include healthcare planning, epidemiological and clinical research, education, policy making, prevention, and follow up ([Table 2](#table2){ref-type="table"}). The most common method of data submission was web-based data entry. The data were entered by a member of the clinical team or a nominated data manager ([Table 3](#table3){ref-type="table"}).

###### General overview of the identified registries

  Region                                                         Country                                                      Name of registry                                                                                                      Responsible institute                                                                                                                                    Internet home page
  -------------------------------------------------------------- ------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------
  Asia                                                           Iran                                                         Electronic Thalassemia Registry (ETR Mazandaran)                                                                      Thalassemia Research Center and Mazandaran University of Medical Sciences                                                                                <http://thr.mazums.ac.ir/>
  Singapore                                                      National Thalassemia Registry (NTR)                          KK Women\'s and Children\'s Hospital                                                                                  <https://www.kkh.com.sg>                                                                                                                                 
  Oman                                                           National Register of Symptomatic Hemoglobinopathies          Genetic Blood Disorders Unit and Ministry of Health                                                                   Unknown                                                                                                                                                  
  Saudi Arabia                                                   Pediatric Non-Malignant Blood DisordersRegistry              King Faisal Specialist Hospital                                                                                       Unknown                                                                                                                                                  
  Europe                                                         Bulgaria                                                     National Registry of Patients with Thalassemia in Bulgaria (NRPTB)                                                    Bulgarian Association for Promotion of Education and Science and Information Centre for Rare Diseases                                                    <https://www.raredis.org>
  United Kingdom                                                 National Haemoglobinopathy Registry (NHR)                    National Health Service                                                                                               <http://nhr.nhs.uk>                                                                                                                                      
  European Haemoglobinopathy Registry(EHR)                       National Health Service                                      <https://www.sicklecellsociety.org/resource/european-haemoglobinopathy-registry/>                                                                                                                                                                                              
  France                                                         Register of Thalassemic Patients in France                   National Institute of Health and Medical Research and National Institute of Health Surveillance                       <https://www.ap-hm.fr>                                                                                                                                   
  Italy                                                          Italian Multiregional Thalassemia Registry (HTA-Thal)        Consorzio per Valutazioni Biologichee Farmacologiche and Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus   <http://www.cvbf.net/tag/hta-thal-registry>                                                                                                              
  Sicilian Registry Thalassemia and Hemoglobinopathies (ReSTE)   Epidemiological Observatory of the Regional Councillorship   <http://pti.regione.sicilia.it>                                                                                                                                                                                                                                                
  Greece                                                         National Registry for Haemoglobinopathies in Greece (NRHG)   Greek Society of Hematology                                                                                           <http://www.enerca.org/members-centers/center/22/national-center-for-thalassaemia-and-haemoglobinopathies-of-laikon-general-hospital-of-athens-greece>   
  Spain                                                          National Registry of Hemoglobinopathies in Spain (REPHem)    Spanish Society of Pediatric Hematology and Oncology                                                                  <https://www.e-clinical.org/rephem/index.aspx>                                                                                                           
  Turkey                                                         Turkish Hemoglobinopathy Registry                            Turkish Society of Pediatric Hematology                                                                               <http://www.tphd.org.tr/>                                                                                                                                
  North America                                                  United States                                                Registry and Surveillance System for Hemoglobinopathies (RuSH)                                                        Centers for Disease Control and National Heart, Lung, and Blood Institute                                                                                <https://www.cdc.gov>
  Canada                                                         Data Information System for Hemoglobinopathies(DISH)         Children's Hospital of Eastern Ontario                                                                                <https://www.project-redcap.org/>                                                                                                                        
  Oceania                                                        Australia                                                    Haemoglobinopathy Registry (HbR)                                                                                      Monash University                                                                                                                                        <http://www.torc.org.au/hbr>

5.. DISCUSSION {#sec5}
==============

Thalassemia registries are essential tools and an important resource for planning and evaluating of disease prevention program based on facts ([@ref26], [@ref28]). In particular they will enhance surveillance of important health conditions, awareness of the prevalence of the disease, better understanding of patient health status, treatment options and detection of shortcomings in the healthcare system ([@ref20], [@ref25], [@ref29]). This was the first review of its kind to compare existing thalassemia registries in worldwide. We identified 16 thalassemia registries, which consisted of 13 national, one multinational and two regional registries.

An important element in determining the feasibility of developing a new registry relates to funding ([@ref21]). Registries with good coverage and accuracy will most likely require significant and sustainable funding sources ([@ref30], [@ref31]). The registries were received funding from various sources, including government agencies, scientific organizations, research collaborators, pharmaceutical manufacturers, accreditation bodies, philanthropic organizations and non-profit organization ([@ref32], [@ref33]). Based on our study most of the thalassemia registries were funded by the government agencies. This tendency might be explained by the superiority of government funding in terms of continuity and predictability, which is required to sustain a thalassemia registry. Clear objectives are essential to define the structure and process of data collection and to ensure that the registry effectively addresses the important questions through the appropriate outcomes analyses ([@ref34], [@ref35]). The purposes of the registry have to be obviously defined and approved upon by the registry sponsors ([@ref36]). Results of this study showed that objectives of most thalassemia registries were improving diagnosis and management of control programs. However, other purposes of thalassemia registries include healthcare planning, epidemiological and clinical research, education, policy making, prevention, and follow-up. Moreover, objectives often overlap, for example, improving diagnosis and prevention can provide improve quality of care. The time and resources needed to collect and process data from a registry can be substantial ([@ref36], [@ref37]).

Registries should define a core data set of essential data elements and patient outcomes that will address the critical questions anticipated by the purpose and objectives for which it was created ([@ref35]). Elements of data to be included must have potential value in the context of the current scientific and clinical climate and must be chosen by a team of experts ([@ref38]). Registries within this review most commonly collected data on: (a) demographics; (b) clinical; (c) complications of disease and therapy; and (d) outcomes. Although, the core minimum data set for thalassemia registries was almost similar in different registries and covered all aspects of quality of care, the number and details of data elements various in different countries.

###### Structures of the identified thalassemia registries

  Registry                                              Type             Year   Funding                            Objectives of registry                                                                                    Disease Coverage                                                     Language    Participation
  ----------------------------------------------------- ---------------- ------ ---------------------------------- --------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------- ----------- ---------------
  ETR Mazandaran                                        Regional         2016   Thalassemia Research Center, Uni   Improving diagnosis, Research, Decision making                                                            Thalassemia major                                                    Persian     Voluntary
  NTR                                                   National         1992   Gov                                Management of control programs,follow- up, Prevention, Counseling and Screening                           Thalassemia major                                                    Unknown     Voluntary
  National Register of Symptomatic Hemoglobinopathies   National         2000   Gov                                Improving diagnosis, Control of blood disorders, Research                                                 Thalassemia major, Sickle cell                                       English     Voluntary
  Pediatric Non-Malignant Blood Disorders Registry      National         2008   Gov                                Management of control programs, Follow-up, Improving diagnosis                                            Thalassemia major, Sickle cell                                       Arabic      Voluntary
  NRPTB                                                 National         2009   Gov                                Improving diagnosis, Follow-up, Prevention, Policy making, Research, Compare management practices         Thalassemia major,Intermedia                                         Bulgarian   Voluntary
  NHR                                                   National         2009   Gov                                Improving care, Management of control programs, Prevention, Research                                      Thalassemia major, Sickle cell                                       English     Voluntary
  EHR                                                   Multi national   2004   Public                             Improving diagnosis, Follow-up, Prevention, Research, Planning                                            Thalassemia major, Otherhemoglobinopathy                             English     Voluntary
  Register of Thalassemic Patients in France            National         2005   Gov                                Improving care, Compare conventional treatment, Research                                                  Thalassemia major, Intermedia                                        French      Voluntary
  HTA-Thal                                              National         2008   Gov,Fondazione Giambrone           Improving diagnosis, Management of control programs, Healthcare planning,Research                         Thalassemia major                                                    Italian     Voluntary
  ReSTE                                                 Regional         1984   Gov                                Management of control programs, Care Planning, Research                                                   Thalassemia major, Intermedia, Sickle cell, Other hemoglobinopathy   Italian     Voluntary
  NRHG                                                  National         2009   Private                            Improving care, Monitor treatment, Prevention, Research                                                   Thalassemia, Sickle cell, Hemoglobin lepore                          Greek       Voluntary
  REPHem                                                National         2014   Industrial Association             Improving diagnosis, Improve Treatment, Prevention, Research,Comparison with other registries             Thalassemia major, Intermedia, Sickle cell                           Spanish     Voluntary
  Turkish Hemoglobinopathy Registry                     National         2012   Gov. Uni                           Improving diagnosis, Management of control programs, Research                                             Thalassemia major, Intermedia, Sickle cell                           Turkish     Voluntary
  RuSH                                                  National         2010   Gov                                Improving care, Monitoring health care utilization and clinical outcomes, Planning, Research, education   Thalassemia, Sickle cell                                             English     Voluntary
  DISH                                                  National         2014   Gov                                Management of control programs, Research, Improving care                                                  Thalassemia ,Sickle cell, Other Hemoglobinopathies                   English     Voluntary
  HbR                                                   National         2014   Industry partners                  Improving diagnosis, Follow-up, Research, Monitoring outcomes                                             Thalassemia major, Sickle cell, Other haemoglobinopathies            English     Voluntary

Accuracy, integrity and completeness of data are the most important elements in the quality and value of any registry ([@ref39]). Low data quality can be due to inadequate collection of data at reporting sites, inattentive abstracting of information from clinical data sources, poor definition and specificity of data, inadequate understanding of complex data elements by those providing the data and lack of incentive and collaboration among reporting centers ([@ref39]-[@ref41]). Comparability of data is essential for interpretation and this in turn, depends on standardization of the methodology and the diagnostic criteria applied ([@ref40]). Effective quality control using regular internal and external audits and monitoring site visits can help to achieve these foremost goals ([@ref33]). Data collection of thalassemia registries from diverse and dispersed sites, including general practice, thalassemia clinics, hematopoietic stem cell transplants, and pediatric hematology centers, is a significant challenge. Procedures and policies to ensure completeness and validity of data should be developed before the data collection commence and reviewed at regular intervals. In addition, good quality information systems are needed for effective data collection to support the registry. Integration of the registry infrastructure with the information and communications technology systems already in place within the national health care systems enables automatic data capture, which significantly reduces the burden of data entry. The web-based data entry was a core feature of the majority of registries within this review. In recent years, the web-based registries have become popular because they are user friendly and can be managed from different locations ([@ref42], [@ref43]).

Additionally, the web-based systems offer the best access to the registry's data, increase the accuracy of data and facilitates real time data entry, updates, reporting and mapping functionalities ([@ref42], [@ref44], [@ref45]). The initial cost to develop a web-based registry can be expensive; however web-based data collection was found to yield a shorter case registration time, lower cost per case to maintain the system and lower rate of error occurrence than the paper-based data collection ([@ref46]). This review had several limitations. The development of thalassemia registries is a new field of research; therefore, the number of included studies is restricted and there was no standard recommendation for reporting the results. We identified a number of gaps in thalassemia registry coverage. Few registries were identified in areas with emerging economies; the majority being based in high income countries, that creating geographic gaps in coverage. In much of the Asia Pacific region, South America and Africa, registries were either absent entirely or had limited data or poor accessibility for outside research. Unfortunately, 2 registries of Cyprus and Malaysia were excluded from the study due to lack of available information.

###### Data collection onthe identified thalassemia registries

  Registry                                              Core minimum data set                                                                                Data sources                                                                     Data submission
  ----------------------------------------------------- ---------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ------------------------------
  ETR Mazandaran                                        Demographics, Clinical, Complications, Medication                                                    Haemoglobinopathy centers                                                        Web-based
  NTR                                                   Demographics, Clinical                                                                               Hospitals                                                                        On-line data transfer
  National Register of Symptomatic Hemoglobinopathies   Administrative, Clinical                                                                             Hospitals, Tertiary care centers                                                 Paper, On-line data transfer
  Pediatric Non-Malignant Blood DisordersRegistry       Demographic, Consanguinity, Diagnostic, Laboratory                                                   Hospitals, Haemoglobinopathy centers                                             Web-based
  NRPTB                                                 Demographic, Diagnostic, Mortality                                                                   Hospitals, Thalassemia centers                                                   Web-based
  NHR                                                   Patient, Adverse Events, Annual Review                                                               Treatment centers, other bodies such as blood and transplant centers             Web-based
  EHR                                                   Demographics, Clinical, Treatment, Laboratory                                                        Hospitals, Haemoglobinopathy Centers                                             On-line data transfer
  Register of Thalassemic Patients in France            Epidemiological, Clinical, Biological                                                                Hospitals, Pediatric centers, stem cell transplants database                     Web-based
  HTA-Thal                                              Demographic,Clinical, Complications, Quality of life,Cost                                            Hospitals, Haemoglobinopathy centers                                             Web-based
  ReSTE                                                 Demographics,Clinical                                                                                Hospital, Haemoglobinopathy centers                                              Paper, fax
  NRHG                                                  Demographic, Disease                                                                                 Hospitals, Haemoglobinopathy centers                                             Web-based
  REPHem                                                Demographic, Clinical                                                                                Hospitals, Haemoglobinopathy centers                                             Web-based
  Turkish Hemoglobinopathy Registry                     Demographic, Disease                                                                                 Hemoglobinopathy centers                                                         Web-based
  RuSH                                                  Administrative, Clinical, Health care utilization                                                    Haemoglobinopathy centers ,Public health records, Clinical records, registries   Paper, On-line data transfer
  DISH                                                  Demographic, Diagnostic, Hospitalizations, transfusions, Tests, Medication, Bone marrow transplant   Hospitals                                                                        Web-based
  HbR                                                   Demographics, Diagnosis, Laboratory , Complications, Clinical outcomes                               Hospitals, Haemoglobinopathy centers, registries, Medical databases              On-line data transfer

The use of English only search words might have resulted in the failure to identify registries in some countries. Therefore, we tried to obtain our necessary information from various peer reviewed articles, reports and web sites. In addition, Contact with authors of the included papers provided valuable detail on registries.

6.. CONCLUSIONS {#sec6}
===============

This analysis confirms the utility of thalassemia registries for the collection of large set of data. In particular, the considerations derived from this data set highlight how the use of large, well monitored patients' registries can guide health authorities and health providers to plan cost efficient services and to meet patients' needs and expectations. We suggest the establishment of an international network for collaboration between thalassemia registries. Global harmonization of data submission methods and minimum data set would facilitate international comparisons. Registries provide a positive return on investment; their establishment and maintenance require ongoing support by government, policy makers, research funding bodies, clinicians and patient with thalassemia.
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